Citigroup Inc. (NYSE:C) recently saw its volume around 22.74 million shares and on average it trades 14.82 million shares a day. The opening price of $75.73, led it to gain 0.61% to reach $75.5 upon the closing bell.Citigroup Inc. (C) Analyst Opinion
Citigroup Inc. has a consensus outperform rating from 31 Wall Street analysts, and the number of shares currently sold short amount to at least 0.98% of shares outstanding. The stock spiked 2.72% last month and is up 27.04 this year. Wall Street is only getting more bullish on the stock, with 18 of analysts who cover C having a buy-equivalent rating. Analysts have placed a $76.47 price target on Citigroup Inc., suggesting a 1.28% gain from recent close. It’s currently trading about -0.84% below its 52-week high.Citigroup Inc. Earnings Surprise
Citigroup Inc. (C) surprised the stock market in its last reported earnings when it earned $1.42 a piece versus the consensus-estimated $1.33. Its revenue totaled $17.9 billion down -0.03% from the previous quarter.
This stock (C) is ahead of its 52-week low with 36.7%. Its last month’s stock price volatility remained 2.18% which for the week stands at 1.58%. The share price has moved forward from its 20 days moving average, trading at a distance of 3.89% and stays 3.41% away from its 50 days moving average. Over the last five days, shares have managed 4.48% gains and now is up 14.69% since hitting its 200-day moving average of $68.46. Citigroup Inc. (C) has made its way to a 12-month gain of 33.89%.
Turning to AbbVie Inc. (NYSE:ABBV), its shares were trading at $96.92 a gain of $1.1, on the trading floor. The stock, after opening at $96.36, touched a high of $97.53 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus call at 2.3. AbbVie Inc. has 5 buy ratings, 11 holds and 0 sells even after the stock tumbled -1.36% from its high of $98.26 to a $154.78 billion market value through last close.AbbVie Inc. (ABBV) Consensus Price Target
The company’s consensus rating on Reuter’s scale slipped from 2.33 to 2.27 during a month. Analysts set a 12-month price target of $97.95 a share. The target implies a 1.06% spike from where the shares are currently trading. Also, the current price highlights a discount of 39.29% to analysts’ high consensus price target.AbbVie Inc. (NYSE:ABBV) Intraday Trading
The counter witnessed a trading volume of 7.91 million shares versus an average volume of 6.79 million shares during last trading session. Its last month’s stock price volatility remained 1.54% which for the week approaches 1.92%. The lowest price the stock reached in the last trading day was $96.21 and compares with the $58.75 52-week low. The stock recovered 64.97% since its low point and has performed 54.77% year-to-date.